-
Analysis: Only 1-in-3 adults ages 18 to 64 years get the flu shot
WASHINGTON — An analysis released Tuesday by the Trust for America's Health found that only 35.7% of adults ages 18 to 64 years got the flu shot last season. By comparison, 56.6% of children ages 6 months to 17 years old and 66.2% of seniors were vaccinated.
"The trend of low vaccination rates among younger adults is particularly troubling this year, when they are more at risk than usual for the effects of the H1N1 strain of flu that's circulating," stated Jeffrey Levi, executive director of TFAH.
-
FDA advisory panel recommends approval of Merck's vorapaxar
WHITEHOUSE STATION, N.J. — Merck on Wednesday commended the U.S. Food and Drug Administration’s Cardiovascular and Renal Drugs Advisory Committee’s recommendation for approval of vorapaxar. Vorapaxar is the company’s investigational antiplatelet medicine for the reduction of atherothrombotic events, when added to standard of care, in patients with a history of heart attack and no history of stroke or transient ischemic attack.